Table 2b.
GMT(95%CI) |
|||
---|---|---|---|
Groups | Type I | Type II | Type III |
Full-dose sIPV | 145.51(34.25, 614.19) | 46.88(6.90, 318.57) | 215.44(49.39, 939.72) |
1/4-dose sIPV | 57.04(13.08, 248.83) | 15.10(2.07, 110.10) | 19.93(1.09, 365.51) |
1/4-dose+AS03 | 524.20(165.20, 2046.44) | 247.46(41.61, 1471.63) | 882.27(600.34, 1296.28) |
1/4-dose+BW006 | 262.12(150.07, 457.72) | 57.04(2.47, 1317.35) | 203.38(58.09, 382.30) |
1/4-dose+Poly:IC | 313.55(83.18, 1181.95) | 43.37(3.76, 500.26) | 110.84(25.44, 482.95) |
1/4 dose+AS03+ BW006 | 1500.38(500.50,4497.80) | 1073.49(462.06,2493.45) | 2097.01(1060.72,4145.72) |
Total | 348.10(224.44, 527.47) | 159.22(81.10, 312.61) | 420.15(224.08, 787.59) |
Note: Full-dose sIPV referred to type I = 30 DU, type II = 32 DU, type III = 45 DU. 1/4-dose referred to type I = 7.5 DU, type II = 8 DU, type III = 11.25 DU
Antibody titer of the second immunization after 28 days was expressed as geometric mean titers (GMT).